Loading Page
Dr. Giancarlo Barolat-Romana, MD is a pain medicine specialist in Denver, CO specializing in pain medicine and neurosurgery. Dr. Giancarlo Barolat-Romana, MD is affiliated with HealthOne and Sarah Cannon Cancer Institute HCA HealthONE Presbyterian St. Luke's HCA HealthONE Rocky Mountain Children's at Presbyterian St. Luke's.
1601 East 19th Avenue Suite 3050
Denver, CO 80218
He completed residency at Medical College of Wisconsin Affiliated Hospitals. He has a state license in Colorado.
Residency: Medical College of Wisconsin Affiliated Hospitals (1985)
Licensed In: Colorado
Dr. Giancarlo Barolat-Romana, MD is associated with these hospitals and organizations:
Dr. Giancarlo Barolat-Romana, MD does not have any reviews yet, be the first to leave a review of Dr. Giancarlo Barolat-Romana, MD here: Leave a Review
These charts describe general payments received by Dr. Giancarlo Barolat-Romana, MD. Doctors may receive payments for a number of reasons, including meal compensation, travel compensation, and consulting.
|
$2,722,500
Algostim $2,722,398 |
Algovita $102 |
|||||
|
$648,941
Pelvistim $648,667 |
Algovita $181 |
Algostim $93 |
||||
|
$508,033
PAIN MANAGEMENT $174,297 |
SPECTRA WAVEWRITER $86,379 |
GENERAL PAIN MANAGEMENT $67,012 |
SPECTRA $46,909 |
OTHER- BSC PRODUCT NOT LISTED $40,363 |
Other $93,072 |
|
|
$17,012
RESTORE $1,244 |
Spinal Cord Neurostimulation - Neuro $529 |
INTELLIS $330 |
SYNCHROMED $125 |
ACTIVOS $105 |
Other $14,680 |
|
|
$13,099
Algovita $13,099 |
||||||
|
$17,837
Senza Spinal Cord Stimulation System $10,724 |
SPRINT PNS System $437 |
ETERNA $297 |
StimRouter for Pain $287 |
Xtampza ER $244 |
Other $5,849 |
| $3,370,235 | |
| $277,088 | |
| $229,811 | |
| $28,246 | |
| $21,756 | |
| $287 |
Dr. Giancarlo Barolat-Romana, MD has received 7 research payments totaling $7,030.
This table describes ownership payments received by Dr. Giancarlo Barolat-Romana, MD.
| SPR Therapeutics, Inc | 2023 | $167,983.09 | Physician Covered Recipient | Series C and D Preferred Shares |
| SPR Therapeutics, Inc | 2022 | $167,983.09 | Physician Covered Recipient | Series C and D Preferred Shares |
| SPR Therapeutics, Inc | 2021 | $167,983.09 | Physician Covered Recipient | Series C and D Preferred Shares |
| BIONESS INC | 2013 | $868.16 | Physician Covered Recipient | Stock Holder |
| BIONESS INC | 2014 | $868.16 | Physician Covered Recipient | Stock Holder |
| BIONESS INC | 2015 | $868.16 | Physician Covered Recipient | Stock Holder |
| BIONESS INC | 2016 | $868.16 | Physician Covered Recipient | Stock Holder |
| BIONESS INC | 2017 | $868.16 | Physician Covered Recipient | Stock Holder |
| BIONESS INC | 2018 | $868.16 | Physician Covered Recipient | Stock Holder. Comment: Bioness is a privately held corporation and does not conduct any stock valuation. So, there is no valuation data apart from the original cost of the stock as of the date of purchase. Hence the value reported (original cost of acquisition) has been constant from year to year. |
Dr. Giancarlo Barolat-Romana is a pain medicine and neurosurgery specialist. Areas of particular interest for Dr. Barolat-Romana include migraine, complex regional pain syndrome (CRPS), and musculoskeletal pain. For his residency, Dr. Barolat-Romana trained at a hospital affiliated with Medical College of Wisconsin. In addition to English, Dr. Barolat-Romana (or staff) speaks Spanish, French, and Italian. He is professionally affiliated with HealthOne.
